Skip to content
AusGrant
Federal Forecasted GRANTS-GOV-363251

Limited Competition: Clinical and Translational Science Awards (CTSA) Program: Collaborative and Innovative Acceleration Award

National Institutes of Health (NIH) · Competitive grant · Science & Technology

At a glance

Limited Competition: Clinical and Translational Science Awards (CTSA) Program: Collaborative and Innovative Acceleration Award is a federal competitive grant from National Institutes of Health for the science & technology sector. Eligible applicants: Others (see text field entitled "Additional Information on Eligibility" for clarification). Eligibility for this NOFO is limited to recipients that have successfully competed for an award under the Clinical and Translati. Applications are accepted on a rolling basis. Apply via the official listing at www.grants.gov.

Amount
See listing
Deadline
Rolling
Type
Competitive
Status
Forecasted

About this program

The purpose of the Congressionally mandated Clinical and Translational Science Award (CTSA) Program is to accelerate the translation of scientific discoveries into treatments, diagnostics, and health interventions that improve patient and public health by funding and coordinating a national network of academic medical centers that provide the infrastructure, expertise, training, and collaboration needed to move discoveries from the laboratory into clinical practice and community health. The purpose of the reissuance of the Collaborative and Innovative Acceleration Award for the CTSA Program Notice of Funding Opportunity (NOFO) is to support the collaborative development of innovative approaches, technologies, or models that synergistically enhance the impact of research, advance translational science, and bring more treatments for all people more quickly. Awards are made under the authorization of Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.This is a Forecast for a Limited Competition that will invite application(s) from eligible organization(s) to apply. Please see Eligibility Section for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding. 

Who can apply

Others (see text field entitled "Additional Information on Eligibility" for clarification). Eligibility for this NOFO is limited to recipients that have successfully competed for an award under the Clinical and Translational Science Awards (CTSA) UM1 NOFO PAR-24-272 or subsequent iterations, as either a prime recipient or as a partnering institution.

How to apply

Apply through Grants.gov using funding opportunity number PAR-28-008. Register your organization (SAM.gov + Grants.gov) before the deadline, then submit the application package listed in the official notice.

Apply at official source